AI
AiXin Life International, Inc.
AIXN · OTC
$0.26 +0.00% (+$0.00)
Market Cap $6.50M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.14
46.2% downside
Current Price
$0.26
Undervalued Fair Value Overvalued
According to Bulios Fair Price, AIXN is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
41 /100
Fair P/S 4.36x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Rev. growth 18.07%
EPS growth N/A
Book val. growth N/A
Profitability
17 /100
Weak Gross margin 41.73%
FCF margin 137.46%
Net margin 137.13%
Quality
66 /100
Average ROIC 50.22%
Asset turnover 0.47x
ROA 63.81%
Debt
0 /100
High Current ratio 0.12x
Int. coverage -133.78x
Debt/Equity N/A
Stability
25 /100
Unstable Beta -3.11x
Profitable years 0
Rev. volatility 56.03%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about AIXN
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Quan Zhong Lin
Employees
116
Headquarters
Chengdu